We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VENU
676
Venu Holding Corp
VENU
$126M
$8K ﹤0.01%
+1,000
New +$11.1K
PRKR
677
DELISTED
Parkervision Inc
PRKR
$8K ﹤0.01%
42,050
+21,500
+105% +$4.09K
XRPN
678
Armada Acquisition Corp II
XRPN
$331M
$8K ﹤0.01%
+798
New +$8.2K
HTFL
679
Heartflow Inc
HTFL
$2.57B
$8K ﹤0.01%
+290
New +$9.34K
PAII
680
Pyrophyte Acquisition Corp II
PAII
$8K ﹤0.01%
870
+770
+770% +$7.74K
BHF icon
681
CALL
Brighthouse Financial
BHF
$3.42B
$7K ﹤0.01%
115
+14
+14% +$823
CLGN icon
682
CollPlant Biotechnologies
CLGN
$5.86M
$7K ﹤0.01%
5,250
– –
CRD.B icon
683
Crawford & Co Class B
CRD.B
$584M
$7K ﹤0.01%
707
+340
+93% +$3.51K
MDU icon
684
MDU Resources
MDU
$4.28B
$7K ﹤0.01%
400
-14
-3% -$276
PML
685
PIMCO Municipal Income Fund II
PML
$495M
$7K ﹤0.01%
1,000
– –
REXR icon
686
Rexford Industrial Realty
REXR
$8.14B
$7K ﹤0.01%
200
+186
+1,329% +$7.67K
RNST icon
687
Renasant Corp
RNST
$3.99B
$7K ﹤0.01%
+200
New +$7.08K
ZENV
688
DELISTED
Zenvia
ZENV
$7K ﹤0.01%
8,000
– –
FLD
689
Fold Holdings
FLD
$25.3M
$7K ﹤0.01%
3,000
– –
BRR
690
ProCap Financial Inc
BRR
$156M
$7K ﹤0.01%
2,200
-46,225
-95% -$369K
ANVS icon
691
Annovis Bio
ANVS
$76.1M
$6K ﹤0.01%
2,000
– –
BTDR icon
692
Bitdeer Technologies
BTDR
$2.37B
$6K ﹤0.01%
550
-132
-19% -$2.13K
COLD icon
693
Americold
COLD
$4.34B
$6K ﹤0.01%
+500
New +$6.13K
CWEN.A
694
DELISTED
Clearway Energy Class A
CWEN.A
$6K ﹤0.01%
+200
New +$6.26K
CYTK icon
695
PUT
Cytokinetics
CYTK
$10.3B
$6K ﹤0.01%
100
– –
GANX icon
696
Gain Therapeutics
GANX
$94.3M
$6K ﹤0.01%
+2,000
New +$5.34K
MSM icon
697
MSC Industrial Direct
MSM
$6.75B
$6K ﹤0.01%
76
-591
-89% -$51.2K
MSOS icon
698
CALL
AdvisorShares Pure US Cannabis ETF
MSOS
$944M
$6K ﹤0.01%
1,310
-902
-41% -$4.02K
SEAT icon
699
Vivid Seats
SEAT
$83.3M
$6K ﹤0.01%
+900
New +$8.85K
STAA icon
700
STAAR Surgical
STAA
$1.25B
$6K ﹤0.01%
270
+220
+440% +$5.67K
26 27
28
29 30

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.